Live
CellHuman-specific features of the cerebellum and ZP2-regulated synapse developmentCellCell-type-specific transposon demethylation and TAD remodeling in aging mouse brainCellPluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapyCellRespiratory viral infections prime accelerated lung cancer growthFierceBiotechInsulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTDFierceBiotechVistagen lays off 20% of staff to tighten focus on struggling social anxiety candidateFierceBiotechPfizer Ignite, designed to accelerate promising biotech therapies, fizzles outScienceRelic of long-vanished ice sheet holds clues to ancient climateAgilentAgilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets - simplywall.stPromega BlogLight Has a Favorite Color, But It’s ComplicatedEndpoints NewsPfizer to close Ignite, its R&D services unit for small biotechsFierceBiotechFledgling French biotech pens $128M deal for Kezar's preclinical protein degrader program
FierceBiotech Mar 12, 2026

Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD

Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD

Original
Body unavailable. Use the original source.

Directory

59 All